Home | Contact us | 
U.S.A. - (Change) - English
U.S.A. - (Change) - English
U.S.A. - (Change) - EnglishCardinal Health is dedicated to providing the latest information on the limited production of Molybdenum (Mo-99), the key isotope used in the production of technetium (Tc99m). As the global shortage continues, please visit our web site regularly to find the latest news and updates on the supply situation. We understand the major impact the shortage has on the nuclear medicine industry’s ability to effectively diagnose and treat patients on a daily basis. We are actively working with our manufacturers and other global partners to find immediate and long-term solutions to this ongoing crisis.
»Consistent with our stated goal of keeping you informed of the global Molybdenum 99 (Mo-99) supply situation through regular communications, Cardinal Health estimates Technetium-99 (Tc-99m) availability for this week through September 4 as follows:
Read more about the shortage, and view estimated Tc-99m availability
»Because the supply shortage is a worldwide problem, nuclear pharmacy providers and all hospitals and clinics are being asked to take measures to conserve supply. Additionally, the advanced warnings of these planned shutdowns have helped the industry prepare for the shortages by discovering alternative methods of meeting demands. Read more about alternative measures you can take in your department.
Feedback: Mo99supplyinfo
